InvestorsHub Logo

krenjp

05/09/08 11:46 AM

#10722 RE: DewDiligence #10685


"The first quarter 2008 research and development expenses also included $5.1 million of expense related to the ATryn program, compared with $4.7 million in the first quarter of 2007. These expenses included cost to manufacture ATryn in excess of the maximum selling price to LEO..."

I am probably not reading this correctly; does the last line mean that manufacturing Atryn costs more than the selling price to LEO???

ThomasS

05/10/08 7:20 AM

#10754 RE: DewDiligence #10685

"While we had hoped to be able to complete this negotiation by this time, our potential partner had become diverted for a time by other corporate activities."

Baxter?